放射肿瘤学市场规模、份额和成长分析（按类型、应用、最终用户、地区）：产业预测（2024-2031）

Radiation Oncology Market Size, Share, Growth Analysis, By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Application (Prostate Cancer, Breast Cancer), By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月10日 | 出版商:

SkyQuest | 英文 172 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球放射肿瘤学（癌症放射治疗）市场规模估值为83.4亿美元，从2023年的93.7亿美元成长到2031年的237亿美元，在预测期内预计将以12.3%的复合年增长率成长（ 2024-2031）。

由于人口老化、生活方式改变和环境影响等因素，癌症盛行率不断上升，推动全球放射肿瘤学市场强劲成长。据世界卫生组织 (WHO) 称，2022 年全球将有约 1,930 万人被诊断出患有癌症，约 1,000 万人将死亡，欧洲将报告 460 万新病例。强度调控放射治疗放射线手术(SRS) 等放射治疗技术的进步正在提高治疗精度并改善患者治疗效果，进一步推动市场扩张。例如，Acure Incorporated 的 Tomo C 放射治疗系统最近在中国获得批准，这是其成长策略的一个重要里程碑。此外，PharmLogic Holdings Corp. 已签订一项基础服务协议，开发针对转移性黑色素瘤和神经内分泌癌的治疗诊断候选药物，为该市场提供持续支持，这表明了技术创新。随着对有效放射肿瘤学的需求持续上升，市场格局将持续发展，使其成为医疗产业研究、开发和投资的重点。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 波湾合作理事会(GCC) 国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

瓦里安医疗系统公司（Siemens Healthineers AG）（美国）
医科达公司（瑞典）
Accuray公司（美国）
IBA Radiopharma Solutions（比利时）
BD（贝克顿迪金森公司）（美国）
艾索瑞公司（美国）
Mevion 医疗系统（美国）
Nordion, Inc. (Sotera Health)（加拿大）
NTP 放射性同位素 SOC Ltd.（南非）
锔（法国）
ViewRay 科技公司（美国）
IBA 全球（比利时）
提供医疗保健（美国）
佳能公司（日本）
日立有限公司（日本）
Icad 公司（美国）
离子束应用（比利时）
Panacea 医疗科技私人有限公司（印度）
P-Cure 有限公司（以色列）

简介目录

Product Code: SQMIG35A2944

Global Radiation Oncology Market size was valued at USD 8.34 billion in 2022 and is poised to grow from USD 9.37 billion in 2023 to USD 23.70 billion by 2031, growing at a CAGR of 12.3% in the forecast period (2024-2031).

The global radiation oncology market is experiencing robust growth, driven by the rising prevalence of cancer, attributed to factors such as an aging population, lifestyle changes, and environmental influences. According to the World Health Organization (WHO), approximately 19.3 million people were diagnosed with cancer worldwide in 2022, resulting in around 10 million deaths, with significant incidences noted in Europe, where 4.6 million new cases were reported. The advancements in radiation therapy technologies, such as intensity-modulated radiation therapy (IMRT) and stereotactic radiosurgery (SRS), are enhancing treatment accuracy and improving patient outcomes, further propelling market expansion. Key players in the industry are actively pursuing strategies to bolster their presence; for instance, Acure Incorporated recently received regulatory approval for its Tomo C radiation therapy system in China, marking a significant milestone in its growth strategy. Additionally, PharmLogic Holdings Corp. has entered a master services agreement to develop theranostic candidates targeting metastatic melanoma and neuroendocrine cancer, showcasing ongoing innovation within the market. As the demand for effective cancer treatments continues to rise, the radiation oncology market is poised for continued development, making it an essential focus area for research and investment in the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Radiation Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Radiation Oncology Market Segmental Analysis

Global Radiation Oncology Market is segmented on the type, application, end user, and region. By type, market is segmented into External Beam Radiation Therapy, and Internal Beam Radiation Therapy. By application, market is segmented into Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Gynecological Cancer, Cervical Cancer, Penile Cancer, and Others. By end user, market is segmented into Hospitals, Specialty Clinics, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Radiation Oncology Market

The surge in global cancer incidence serves as a primary catalyst for the growth of the radiation oncology market. With cancer ranking as one of the foremost causes of mortality across diverse demographics, there is an escalating demand for advanced treatment modalities, particularly radiation therapy. This heightened need prompts substantial investments in innovative radiation technologies and oncology solutions, facilitating enhanced patient outcomes and expanding market accessibility. Additionally, ongoing research and development efforts aim to improve treatment efficacy and minimize side effects, thereby driving the adoption of radiation oncology in clinical settings. Together, these factors collectively bolster the expansion of the global radiation oncology market.

Restraints in the Global Radiation Oncology Market

The Global Radiation Oncology market faces significant restraints due to the prohibitive costs associated with radiation therapy and its advanced equipment. High investment requirements for sophisticated technologies, such as linear accelerators and imaging systems, can be a barrier for numerous healthcare providers, particularly in low- and middle-income countries where budget constraints are prevalent. This financial burden limits the availability of essential radiation treatment services, restricting access for patients and dampening overall market penetration. Consequently, the inability to implement cutting-edge radiation oncology solutions in underserved regions stifles market expansion and inhibits the adoption of potentially life-saving cancer therapies.

Market Trends of the Global Radiation Oncology Market

The Global Radiation Oncology market is witnessing a significant trend towards the increasing adoption of proton therapy, characterized by its enhanced precision in targeting tumors while minimizing damage to adjacent healthy tissues. This advanced treatment modality is becoming increasingly recognized for its efficacy, particularly in treating complex cancers, fostering greater patient outcomes. As awareness rises and technological advancements reduce costs, demand for proton therapy is anticipated to surge, subsequently catalyzing growth and innovation throughout the radiation oncology sector. Consequently, this trend not only reflects a shift in clinical practices but also indicates a broader commitment to personalized cancer care solutions in the healthcare landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
PESTEL Analysis
Technology Analysis
Regulatory Analysis
Market Attractiveness Index, 2023
Case Study Analysis

Radiation Oncology Market, By Type

Market Overview
External Beam Radiation Therapy
- Conformal Radiation Therapy
- Proton Beam Therapy
- Image-guided Radiation Therapy
- Stereotactic Radiation Therapy
- Others
Internal Beam Radiation Therapy
- Brachytherapy
- Systemic Beam Radiation Therapy
- Others

Radiation Oncology Market, By Application

Market Overview
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Gynecological Cancer
Cervical Cancer
Penile Cancer
Others

Radiation Oncology Market, By End User

Market Overview
Hospitals
Specialty Clinics
Others

Radiation Oncology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Varian Medical Systems, Inc. (Siemens Healthineers AG) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Radiopharma Solutions (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isoray Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mevion Medical Systems (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion, Inc. (Sotera Health) (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NTP Radioisotopes SOC Ltd. (South Africa)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ViewRay Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBA Worldwide (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Provision Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icad Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ion Beam Applications (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Medical Technologies Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
P-Cure Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments